Key statistics dashboard for NeoGenomics, Inc. (NEO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers.
Stock Data
| Price | $19.59 |
| Market Cap | $503M |
| Enterprise Value | $813.9M |
| Beta | 1.71 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -10.03 |
| Price / Book | 0.66 |
| P/S | 0.67 |
| EV/EBITDA | 63.16 |
| EV/Sales | 1.06 |
| EV/FCF | -110.66 |
| P/FCF | -69.49 |
| Earnings Yield | -10.06% |
| FCF Yield | -1.44% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 42.92% |
| EBIT Margin | -6.86% |
| EBITDA Margin | 1.68% |
| Operating Margin | -8.63% |
| Net Margin | -6.77% |
| Return on Equity | -6.31% |
| Return on Assets | -3.84% |
| Return on Invested Capital | -5.03% |
| Return on Capital Employed | -5.31% |
Financial Health
| Current Ratio | 3.60 |
| Quick Ratio | 3.35 |
| Cash Ratio | 1.37 |
| Debt / Equity | 0.57 |
| Debt / Assets | 33.16% |
| Net Debt / EBITDA | 23.50 |
| Interest Coverage | -25.64 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.53 |
Per-Share Data
| Revenue per share | 29.56 |
| Book Value per share | 30.34 |
| Cash per share | 5.61 |
| FCF per share | -0.28 |
| Tangible Book Value per share | -0.33 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 1 |
| Buy | 22 |
| Hold | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 29 |
| Avg rating (1-5) | 0.79 |
Related companies: ACRS · ARCT · HUMA · MDXH · QTRX · SGMT · SMTI
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NEO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks